Turkish Journal of Anaesthesiology & Reanimation
Perioperative Care - CASE REPORT

Anaesthetic Management of a Patient with Brugada Syndrome in Total Knee Arthroplasty

1.

Department of Anaesthesiology and Reanimation, Başkent University Faculty of Medicine, Ankara, Turkey

2.

Department of Cardiology, Başkent University Faculty of Medicine, Ankara, Turkey

Turk J Anaesthesiol Reanim 2021; 49: 70-73
DOI: 10.5152/TJAR.2020.179
Read: 102 Downloads: 64 Published: 24 December 2020

We report the case of a 52-year-old female diagnosed with Brugada syndrome (BrS) scheduled to undergo right total knee arthroplasty. General anaesthesia was induced and maintained with thiopental intravenous sodium + remifentanil and sevoflurane + remifentanil infusion, respectively. Rocuronium bromide was used as the muscle relaxant. The defibrillator was ready for use with the electrodes on the patient. Sugammadex was used for muscle relaxant antagonization. Postoperative analgesia was provided by intermittent morphine HCL via an epidural catheter, intravenous patient-controlled analgesia (Meperidine), and intravenous tenoxicam. The patient was discharged on the 6th day without any problem. Anaesthetic management of patients with BrS is challenging for anaesthesiologists, because fatal cardiac arrhythmias can be triggered by many drugs commonly used in the perioperative period such as bupivacaine, lidocaine, neostigmine, propofol, succinylcholine, ketamine, and tramadol. In these cases, a detailed preoperative evaluation including family history, avoidance of drugs triggering arrhythmia, taking precautions against arrhythmia, and using the agents that are reported to be safe are essential for patient safety.

Cite this article as: Tuncalı B, Kökten G, Altın C. Anaesthetic Management of a Patient with Brugada Syndrome in Total Knee Arthroplasty. Turk J Anaesthesiol Reanim 2021; 49(1): 70-3.

Files
EISSN 2667-6370